AGER and COVID-19: Hyperglycemia upregulates receptor for advanced glycation end products (RAGE), a major mediator of pulmonary inflammatory responses including those in COVID-19, and RAGE ligands such as sepsis-associated HMGB1 [181], and this activates NF-κB via a positive regulation loop [182].